Dynamic supraparticles for the treatment of age-related diseases

查看全文 作　　者：Hongwei [1]Liao;Zeyu [1]Liang;Nan [1]Wang;Min [1]Wei;Ying [1]Chen;Fangyuan [1,2]Li;Daishun [1,2]Ling

机构地区：[1]Institute of Pharmaceutics and Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;[2]Key Laboratory of Biomedical Engineering of the Ministry of Education,College of Biomedical Engineering and Instrument Science,Zhejiang University,Hangzhou 310058,China

出　　处：《Science Bulletin》索引2019年第64卷第24期,共25页

基　　金：supported by the National Key Research and Development Program of China (2016YFA0203600);the National Natural Science Foundation of China (31822019,51703195,and 91859116);One Belt and One Road International Cooperation Project from Key Research and Development Program of Zhejiang Province (2019C04024);the Zhejiang Provincial Natural Science Foundation (LGF19C100002);the Fundamental Research Funds for the Central Universities (2018QNA7020);‘‘Thousand Talents Program” for Distinguished Young Scholars 摘　　要：Age-related diseases(ARDs) are arising as a major threat to public health in our fast-aging society.Current development of nanomedicine has sparked much optimism toward ARDs management by improving drug delivery and controlled drug release. However, effective treatments for ARDs, such as cancer and Alzheimer’s diseases(AD), are still lacking, due to the complicated pathological features of ARDs including multifactorial pathogenesis, intricate disease microenvironment, and dynamic symptom manifestation. Recently, dynamic supraparticles(DS), which are reversibly self-assembled functional nanoparticles, have provided a novel strategy for combating ARDs. Besides the intrinsic advantages of nanomedicine including multifunctional and multitarget, DS are capable of dynamic structural reconfiguration upon certain stimulation, creating another layer of maneuverability that allows programmed response to the spatiotemporal alterations of ARDs during progression and treatment. In this review,we will overview the challenges faced by ARDs management, and discuss the unique opportunities brought by DS. Then, we will summarize the designed synthesis of DS for ARDs treatment. Finally, we will dissect the therapeutic targets in ARDs that can be exploited by DS, and present the encouraging advances in this field. Hopefully, this review will bridge our knowledge of the design principle of DS and ARDs management, which may inspire the future development of potent theranostic agents to improve the healthcare. 关键词：Dynamic supraparticles Age-related diseases NANOMEDICINE STIMULI-RESPONSIVE

相关文献

参考文献（156）
引证文献（2）
耦合文献（24）

参考文献(156)

引证文献(2)

耦合文献(24)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Dynamic supraparticles for the treatment of age-related diseases

参考文献(156)

引证文献(2)

耦合文献(24)

用户提示